Cairo – Mubasher: The Listing Committee of the Egyptian Exchange (EGX) has decided to approve the listing of the issued and paid-up capital increase shares of Cleopatra Hospital Company from EGP 724,725,042 to EGP 733,906,973.
In a statement today, the EGX stated that this represents an increase of EGP 9,181,931 through the issuance of 18,363,862 shares with a par value of EGP 0.50 per share.
It clarified that the capital increase shares shall be fully allocated to the reward and incentive scheme as follows:
• Allocating 3,869,415 shares of the said increase for the execution of the third tranche for the year 2023 and the second tranche for the year 2024 under the primary reward and incentive scheme approved by the Financial Regulatory Authority (FRA) on 10/12/2020.
• Allocating 14,494,447 shares for the execution of the first tranche for the year 2026 under the extended reward and incentive scheme approved by the Financial Regulatory Authority (FRA) on 14/10/2025, bringing the total increase shares allocated to the primary reward and incentive scheme and its extension to 18,363,862 shares.
It pointed out that this increase is funded from the retained earnings balance appearing in the financial statements ended 31/12/2025.
The Committee approved the inclusion of the company's shares following the increase on the database, setting a reference price for the company's shares as of the start of the trading session on Tuesday, 27/10/2026.
